Your session is about to expire
← Back to Search
Brain Training for Mild Cognitive Impairment
N/A
Recruiting
Led By Joseph Gullett, Ph.D.
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to week 12 during follow-up
Awards & highlights
Study Summary
This trial will use AI to predict if brain training will help older adults with memory loss, using MRI scans.
Who is the study for?
This trial is for older adults with mild cognitive impairment who have a close informant to report on their cognition, can handle daily activities despite some difficulties, and score within normal limits on a cognitive screening. They must not be dependent on certain medications or have conditions like dementia, major psychiatric disturbances, uncontrolled medical issues, or past participation in similar studies.Check my eligibility
What is being tested?
The TRAIN study uses brain MRI data from participants to train an AI tool that predicts how well they'll respond to computerized cognitive training designed for those with memory impairments. Participants will either receive this training or educational training (control) over 12 weeks.See study design
What are the potential side effects?
Since the interventions involve non-invasive cognitive training and computer exercises, there are no direct physical side effects expected from participating in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline up to week 12 during follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to week 12 during follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Useful Field of View Composite
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group: Cognitive TrainingExperimental Treatment1 Intervention
Participants will complete computerized cognitive training via Posit Science Brain HQ. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Group II: Active Control Group: Computerized Cognitive StimulationActive Control1 Intervention
Participants will complete cognitively-stimulating computer activities. The duration is 60 min/day; the frequency is two to three days/wk, for 16 weeks with the goal of completing 40 sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Training
2008
Completed Phase 3
~4100
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,341 Previous Clinical Trials
715,571 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,810 Total Patients Enrolled
Joseph Gullett, Ph.D.Principal InvestigatorUniversity of Florida
1 Previous Clinical Trials
20 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have any uncontrolled health conditions or a current cancer diagnosis.I do not have significant vision or hearing loss that would prevent me from participating in study tasks.I haven't used any photo-sensitive medications like steroids or retin-A in the last 15 days.I am not taking antipsychotics, sedatives, or drugs that heavily affect memory.Despite cognitive issues, I can manage daily tasks on my own.I can commit to a 12-week program with extra time for tests before and after.I have not had major strokes, brain diseases like Parkinson's, or significant brain surgeries.I am open to being assigned to either the control or the intervention group.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group: Cognitive Training
- Group 2: Active Control Group: Computerized Cognitive Stimulation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor recruiting seniors above the age of 75?
"According to the study's eligibility requirements, participants must range in age from 55 years old to 100 years old."
Answered by AI
Who is the ideal cohort to include in this research project?
"This medical trial is seeking 75 individuals with mild cognitive impairment, aged between 55 to 100 years. Qualifying participants will be admitted into the research project."
Answered by AI
Is this study still accepting subjects for participation?
"The clinicaltrials.gov website reports that this medical trial, first posted on July 1st 2023 and last edited June 6th 2023, is not currently recruiting participants. However, there are an abundance of other trials with open enrollment at the moment - 610 to be exact."
Answered by AI
Who else is applying?
What site did they apply to?
University of Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
Why did patients apply to this trial?
I have not been prescribed anything that might help improve my menory. I can only keep one thought/task in focus at a time. If interuppted, I've forgotten what I was going to to. When getting somthing from another room, I often forget what I went loooking for by the time I get there. My insurance initialy denied my claim, I got an attorney to facilitate. I'm currently on disability after failing an IME in January and having The Hartford denial overturmed.
PatientReceived no prior treatments
Share this study with friends
Copy Link
Messenger